The effects of 17β‐estradiol (E2) on dopamine (DA) transport could explain gender and life‐stage differences in the incidence of some neurological disorders. We tested the effects of E2 at physiological concentrations on DA efflux in nerve growth factor‐differentiated rat pheochromocytoma cells that express estrogen receptors (ER) α, ERβ, and G‐protein coupled receptor 30 (GPR30), and DA transporter (DAT). DAT efflux was determined as the transporter‐specific loss of 3H‐DA from pre‐loaded cells; a 9–15 min 10−9 M E2 treatment caused maximal DA efflux. Such rapid estrogenic action suggests a non‐genomic response, and an E2‐dendrimer conjugate (limited to non‐nuclear actions) caused DA efflux within 5 min. Efflux dose–responses for E2 were non‐monotonic, also characteristic of non‐genomic estrogenic actions. ERα siRNA knockdown abolished E2‐mediated DA efflux, while ERβ knockdown did not, and GPR30 knockdown increased E2‐mediated DA efflux (suggesting GPR30 is inhibitory). Use of ER‐selective agonists/antagonists demonstrated that ERα is the predominant mediator of E2‐mediated DA efflux, with inhibitory contributions from GPR30 and ERβ. E2 also caused trafficking of ERα to the plasma membrane, trafficking of ERβ away from the plasma membrane, and unchanged membrane GPR30 levels. Therefore, ERα is largely responsible for non‐genomic estrogenic effects on DAT activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.